Biotech Stocks

Barclays Has New Plays for Healthcare Fans

Investment banker Barclays announced it has initiated coverage of 20 U.S.

Foamix (FOMX): A Beaten-Down Biotech Stock That Looks Like a Bargain Now

Get ready, bargain shoppers. Foamix (FOMX) has plummeted 27% since the beginning of the year and it looks like the stock received more …

Spooked Investors Sent Catalyst (CPRX) Stock Spiraling, But Analysts Remain Confident

This week turned out to be a nightmare for shareholders of Catalyst Pharmaceuticals (CPRX), as the stock price plummeted nearly 55%. What’s causing …

Why Did Amarin (AMRN) Stock Sink After Earnings? Analysts Explain

Anti-cholesterol drugmaker Amarin (AMRN) reported a better-than-expected $0.07-per-share loss on Wednesday on $73.

Is the Worst Over for Zogenix (ZGNX) Stock?

Zogenix (ZGNX) is one of the pharma’s biggest losers today. The reason?

Analyst Sings the Praises of Amarin (AMRN) Stock Following ADA Endorsement

With primary care clinicians playing an ever-increasing role in the management of diabetes, staying on top of new developments in the American Diabetes …

Stifel on Amarin (AMRN): Nothing Fishy About This Stock — It’s a Buy!

Do you have high cholesterol? Investors in Amarin (AMRN) kind of hope that you do — but ideally, not too high.

This Analyst Takes Biogen (BIIB) Alzheimer’s Failure Personally

It’s a short and dramatic plunge for Biogen (BIIB) stock. Today, the biotech giant’s shares lost 29% of their value and reached levels …

Spark Therapeutics (ONCE): Did You Feel the Ground Shake, Too?

It’s a very rewarding trading day for investors in Spark Therapeutics (ONCE) with shares skyrocketing 120%, making the stock Wall Street’s bull of …

Keep Faith in Bausch Health (BHA) Stock, Say Analysts

Bausch Health (BHC) saw its shares crater by as much as 10% today on exceptionally high volume. This drop was triggered by the release …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts